NEUTROGENA T/GEL SHAMPOO coal tar 5mg/mL application bottle Australia - English - Department of Health (Therapeutic Goods Administration)

neutrogena t/gel shampoo coal tar 5mg/ml application bottle

johnson & johnson pacific pty ltd - coal tar, quantity: 5 mg/ml - application - excipient ingredients: sodium chloride; edetate sodium; cocamidopropyl betaine; citric acid; purified water; cocamide dea; sodium laureth sulfate; coal tar; laureth-4; fragrance (perfume); propylene glycol; propyl hydroxybenzoate; methyl hydroxybenzoate; diazolidinyl urea - helps control scalp itching and flaking symptomatic of scalp psoriasis, eczema, seborrhoeic dermatitis and dandruff.

COAL TAR-DRLA FOAM coal tar 2% w/w foam aerosol can Australia - English - Department of Health (Therapeutic Goods Administration)

coal tar-drla foam coal tar 2% w/w foam aerosol can

dr reddys laboratories australia pty ltd - coal tar, quantity: 10 % w/w (equivalent: coal tar, qty 2 % w/w); xanthan gum, quantity: 0.25 % w/w - spray, pressurised - excipient ingredients: glycerol; purified water; propane; phenoxyethanol; butane; stearic acid; cyclomethicone; peppermint oil; dimeticone 360; disodium edetate; medium chain triglycerides; isobutane; sodium citrate dihydrate; potassium sorbate; cetostearyl alcohol; isopropyl myristate; citric acid; hypromellose; fragrance (perfume) - use to assist in the relief of the symptoms of psoriasis

Gold Cross Codeine Linctus codeine phosphate hemihydrate 5 mg/mL oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

gold cross codeine linctus codeine phosphate hemihydrate 5 mg/ml oral liquid bottle

inova pharmaceuticals (australia) pty ltd - codeine phosphate hemihydrate, quantity: 5 mg/ml - oral liquid - excipient ingredients: glycerol; propylene glycol; purified water; sucrose; methyl hydroxybenzoate - relief of unproductive, dry and intractable coughs associated with colds and flu relief of unproductive, dry and intractable coughs associated with colds and flu.

SCYTERA (COAL TAR) FOAM, 2%- coal tar foam, 2% aerosol, foam United States - English - NLM (National Library of Medicine)

scytera (coal tar) foam, 2%- coal tar foam, 2% aerosol, foam

dpt laboratories, ltd. - coal tar (unii: r533eso2ec) (coal tar - unii:r533eso2ec) - coal tar 20 mg in 1 g - - for prolonged periods without consulting a doctor - this product in or around the rectum or in the genital area or groin except on the advice of a doctor

COCO-SCALP coal tar solution 12% w/w, salicylic acid 2% w/w and sulfur-precipitated 4% w/w ointment tube Australia - English - Department of Health (Therapeutic Goods Administration)

coco-scalp coal tar solution 12% w/w, salicylic acid 2% w/w and sulfur-precipitated 4% w/w ointment tube

aft pharmaceuticals pty ltd - coal tar solution, quantity: 12 % w/w; precipitated sulfur, quantity: 4 % w/w; salicylic acid, quantity: 2 % w/w - ointment - excipient ingredients: peg-20 glyceryl stearate; white soft paraffin; liquid paraffin; glycerol; cetostearyl alcohol; coconut oil; hard paraffin - coco-scalp is for the treatment of dry scaly skin disorders of the scalp such as psoriasis, seborrhoiec dermatitis, eczema and dandruff

SERENACE INJECTION haloperidol 5 mg/mL ampoule 1mL Australia - English - Department of Health (Therapeutic Goods Administration)

serenace injection haloperidol 5 mg/ml ampoule 1ml

aspen pharmacare australia pty ltd - haloperidol, quantity: 5 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; (s)-lactic acid - chronic therapy: the management of manifestations of psychotic disorders such as schizophrenia, psychosis due to organic brain damage or mental deficiency, the manic phase of manic depressive illness, gilles de la tourette syndrome. short term therapy: the treatment of acute alcoholism for the relief of delusions, hallucinations and confused states, and for the control of accompanying tremulousness and aggressive behaviour. in the treatment of intractable nausea and vomiting associated with radiation or malignancy and not responding to other therapy. neuroleptanalgesia

Actacode Codeine Linctus (Chloroform-free) codeine phosphate hemihydrate 5 mg/mL oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

actacode codeine linctus (chloroform-free) codeine phosphate hemihydrate 5 mg/ml oral liquid bottle

arrotex pharmaceuticals pty ltd - codeine phosphate hemihydrate, quantity: 5 mg/ml - oral liquid, solution - excipient ingredients: glycerol; propylene glycol; sucrose; purified water; potassium sorbate; hydrochloric acid; sodium hydroxide; methyl hydroxybenzoate; propyl hydroxybenzoate; ethyl hydroxybenzoate; butyl hydroxybenzoate; isobutyl hydroxybenzoate - relief of unproductive, dry and intractable coughs associated with colds and flu.

FAULDING PSORIAFOAM Coal Tar 2% w/w Foam Aerosol Can Australia - English - Department of Health (Therapeutic Goods Administration)

faulding psoriafoam coal tar 2% w/w foam aerosol can

dr reddys laboratories australia pty ltd - coal tar solution, quantity: 10 % w/w (equivalent: coal tar, qty 2 % w/w) - spray, pressurised - excipient ingredients: phenoxyethanol; hypromellose; citric acid; cyclomethicone; xanthan gum; stearic acid; propane; butane; isopropyl myristate; cetostearyl alcohol; potassium sorbate; glycerol; isobutane; sodium citrate dihydrate; dimeticone 360; peppermint oil; purified water; disodium edetate; medium chain triglycerides; fragrance (perfume) - use to assist in the relief of the symptoms of psoriasis

RIVOTRIL clonazepam 2.5mg/mL oral liquid bottle Australia - English - Department of Health (Therapeutic Goods Administration)

rivotril clonazepam 2.5mg/ml oral liquid bottle

pharmaco australia ltd - clonazepam, quantity: 2.5 mg/ml - oral liquid, solution - excipient ingredients: saccharin sodium; propylene glycol; brilliant blue fcf; glacial acetic acid; flavour - tablets. most types of epilepsy in infants and children, especially absences (petit mal), myoclonic seizures and tonic-clonic fits, whether due to primary generalised epilepsy, or to secondary generalisation of partial epilepsy. in adults all varieties of generalised epilepsy, (including myoclonic, akinetic, tonic and tonic-clonic seizures), and in partial epilepsy (including psychomotor seizures). injection. intravenous use for status epilepticus only. note. efficacy by the intramuscular route has not need demonstrated.

IOPIDINE apraclonidine 5mg/mL (as hydrochloride) eye drops bottle Australia - English - Department of Health (Therapeutic Goods Administration)

iopidine apraclonidine 5mg/ml (as hydrochloride) eye drops bottle

clinect pty ltd - apraclonidine hydrochloride, quantity: 5.75 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; sodium acetate; sodium chloride; hydrochloric acid; sodium hydroxide; purified water - to control intraocular pressure in glaucoma patients on maximally tolerated glaucoma therapy for a period of 3 months. in clinical studies the drop in intraocular pressure (iop) appeared to decrease after day 60 which may be associated with a progression of the disease or loss of effect of the drug. this phenomenon appears to be an individual occurence with a variable time of onset. as with any patient on maximally tolerated therapy (see dosage & administration), patients using apraclonidine 0.5% eye drops to delay surgery should have frequent follow-up examinations and treatment should be discontinued if iop rises significantly. in patients who have maintained a response to apraclonidine 0.5% eye drops for 3 months and a decision is made to continue treatment, safety aspects, including any evidence of corneal changes (see warnings and precautions), and iop control should be closely monitored.